Stay updated on GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.

Latest updates to the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe changes modify publication metadata by adding statements that publications are provided voluntarily and automatically filled from PubMed, and by updating the revision label to v3.3.2, while removing the prior wording about PubMed-derived publications and the v3.2.0 revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedA government funding/operating status notice was removed from the page. The study details, including the NCT number, title, endpoints, and listed locations, remain unchanged.SummaryDifference0.3%

- Check48 days agoChange Detected- Minor user interface and formatting updates with no changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedIntroducing a major status notice about funding-related operation limitations and updating the version to v3.2.0. The page now communicates potential processing delays and directs users to official sources, marking a shift in reliability and availability information.SummaryDifference2%

- Check83 days agoChange DetectedAdded a new version tag (v3.1.0) and removed several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating a content restructuring.SummaryDifference0.2%

- Check98 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed; no changes to core content or pricing are detected.SummaryDifference0.1%

Stay in the know with updates to GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.